Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adastra Labs Holdings Ltd. ( (TSE:XTRX) ) just unveiled an announcement.
Adastra Holdings Ltd. announced that its wholly owned subsidiary, Adastra Labs Inc., has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment, along with packaging and labelling machinery, to an arm’s length buyer for $166,225. Under a related lease agreement, the purchaser will lease the equipment back to Adastra Labs for an annual fee, a move the company says is designed to strengthen its balance sheet and reduce debt without materially affecting operations.
The company also disclosed that director Mark Qvist has resigned from the board, effective February 28, 2026. The leadership change comes as Adastra continues to refine its capital structure and operational footprint within Canada’s competitive cannabis manufacturing and extraction market.
The most recent analyst rating on (TSE:XTRX) stock is a Hold with a C$0.20 price target. To see the full list of analyst forecasts on Adastra Labs Holdings Ltd. stock, see the TSE:XTRX Stock Forecast page.
Spark’s Take on TSE:XTRX Stock
According to Spark, TipRanks’ AI Analyst, TSE:XTRX is a Neutral.
The overall stock score is primarily impacted by the company’s poor financial performance, which is the most significant factor. Technical analysis provides some moderate support, but the negative valuation metrics further weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on TSE:XTRX stock, click here.
More about Adastra Labs Holdings Ltd.
Adastra Holdings Ltd. is a Canadian producer and manufacturer of ethnobotanical and cannabis products for the legal adult-use and medical markets. Operating a Health Canada-licensed facility, it specializes in extraction, distillation and manufacturing of cannabis concentrates sold under the Phyto Extractions and Endgame Extracts brands through more than 2,000 retail locations across Canada.
Average Trading Volume: 2,649
Technical Sentiment Signal: Sell
Current Market Cap: C$1.12M
For a thorough assessment of XTRX stock, go to TipRanks’ Stock Analysis page.